XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating activities:        
Net income (loss) $ (898) $ (259) $ (1,136) $ (1,211)
Adjustments to reconcile net income (loss) to net cash provided by operations:        
Depreciation and amortization 300 358 604 681
Impairment of goodwill, long-lived assets and assets held for sale 774 810 962 975
Net change in operating assets and liabilities 204 354 (160) 913
Deferred income taxes – net and uncertain tax positions (44) (1,083) (150) (1,258)
Stock-based compensation 30 39 62 63
Other items (12) (107) 23 (77)
Net loss (gain) from investments and from sale of long lived assets (30) 11 (26) (12)
Net cash provided by (used in) operating activities 324 123 179 74
Investing activities:        
Beneficial interest collected in exchange for securitized trade receivables 371 287 694 592
Purchases of property, plant and equipment (119) (127) (258) (284)
Proceeds from sale of business and long lived assets 56 18 58 43
Acquisition of businesses, net of cash acquired 0 0 0 (7)
Purchases of investments and other assets (2) 0 (6) (4)
Proceeds from sale of investments 0 3 0 3
Other investing activities (4) (2) (5) (2)
Net cash provided by (used in) investing activities 302 179 483 341
Financing activities:        
Repayment of senior notes and loans and other long term liabilities 0 (296) (3,152) (296)
Proceeds from senior notes, net of issuance costs 0 0 2,451 0
Other financing activities (55) (42) (60) (40)
Net cash provided by (used in) financing activities (55) (338) (761) (336)
Translation adjustment on cash and cash equivalents (77) (123) (65) (185)
Net change in cash, cash equivalents and restricted cash 494 (159) (164) (107)
Balance of cash, cash equivalents and restricted cash at beginning of period 2,176 2,250 2,834 2,198
Balance of cash, cash equivalents and restricted cash at end of period 2,670 2,091 2,670 2,091
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:        
Cash and cash equivalents 2,669 2,058 2,669 2,058
Restricted cash included in other current assets 1 33 1 33
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 2,670 2,091 2,670 2,091
Non-cash financing and investing activities:        
Beneficial interest obtained in exchange for securitized accounts receivables $ 380 $ 291 $ 714 $ 590